← Leaderboards
Jessica L Reynolds
State University Of New York At Buffalo
$3,618,581
Attributed
$3,678,081
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $478.5K · FY2006–24$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,678,081 · 5
By mechanism
R01$2,235,592 · 1
K01$782,202 · 1
R21$442,063 · 1
R56$119,000 · 1
F32$99,224 · 1
Top collaborators
- Paras N. Prasad1 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Matthew D Disney$28,195,698
- Brian Tsuji$5,737,626
- Dhaval K Shah$3,768,811
- Michael R Detty$887,691
- Steve Goodison$11,872,929
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleHiv-1In VitroSurfaceMacrophageInnovationResearch PersonnelPathogenesisBaseCellsInsightDoseDrug KineticsDrug Delivery SystemsImmune SystemMouse ModelMycobacterium TuberculosisCytokineDectin 1In VivoCommunicable DiseasesCessation Of LifeGlycolatesInflammatory
Grant awards (15)
Immunotherapeutic nanoparticles: Implications for the treatment of tuberculosis and HIV$201,250
R21 · FY2024 · AI · contact PI
Immunotherapeutic nanoparticles: Implications for the treatment of tuberculosis and HIV$240,813
R21 · FY2023 · AI · contact PI
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeuticnanoparticles for TB$436,239
R01 · FY2022 · AI · contact PI
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeuticnanoparticles for TB$460,961
R01 · FY2021 · AI · contact PI
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeutic nanoparticles for TB$470,531
R01 · FY2020 · AI · contact PI
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeutic nanoparticles for TB$478,506
R01 · FY2019 · AI · contact PI
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeutic nanoparticles for TB$389,355
R01 · FY2018 · AI · contact PI
Pharmacokinetics and immunodynamics of multimodal nanoparticles for HIV and TB$119,000
R56 · FY2014 · AI · contact PI
Methamphetamine and HIV-1 Infection: Targeted Nanoparticles for Gene Silencing.$160,082
K01 · FY2012 · DA · contact PI
Methamphetamine and HIV-1 Infection: Targeted Nanoparticles for Gene Silencing.$160,082
K01 · FY2011 · DA · contact PI
Methamphetamine and HIV-1 Infection: Targeted Nanoparticles for Gene Silencing.$156,988
K01 · FY2010 · DA · contact PI
Methamphetamine and HIV-1 Infection: Targeted Nanoparticles for Gene Silencing.$153,983
K01 · FY2009 · DA · contact PI
Methamphetamine and HIV-1 Infection: Targeted Nanoparticles for Gene Silencing.$151,067
K01 · FY2008 · DA · contact PI
Mechanisms of Cocaine-Induced HIV-1 infection in NHA$50,428
F32 · FY2007 · DA · contact PI
Mechanisms of Cocaine-Induced HIV-1 infection in NHA$48,796
F32 · FY2006 · DA · contact PI